A Short History of Vaccines: From Smallpox to COVID

In This Article

One of the most transformative achievements in medical history, vaccines have saved countless lives by containing infectious diseases that once decimated populations. By training the immune system to recognize and combat pathogens without causing illness, vaccines have helped eradicate deadly diseases, reduced global mortality rates, and extended human lifespans.

The full impact of vaccines extends beyond individual health, as they’ve played a significant role in improving public health and health outcomes worldwide. By exploring key vaccination milestones, including Edward Jenner’s smallpox breakthrough and the rapid development of COVID-19 vaccines, we highlight the scientific, social, and public health developments that have made vaccines one of the cornerstones of modern medicine.

With the future likely to involve the navigation of ongoing challenges like vaccine hesitancy and global inequality, understanding the history of vaccines highlights the critical role they’re likely to play in our collective future.

The Beginnings of Vaccination

The idea of immunization predates modern science and is rooted in a practice known as variolation, which emerged independently across a variety of ancient cultures. Variolation involves deliberately exposing healthy individuals to small amounts of infectious material from a diseased person to induce mild illness and subsequent immunity.

In 10th-century China, practitioners used dried smallpox scabs ground into powder and inhaled or applied to scratched skin to protect against severe smallpox infections. This method reduced mortality but carried risks, as some recipients developed full-blown smallpox or spread the disease.

In India, 8th-century Hindu texts describe similar practices, with smallpox pus applied to the skin. African nomadic tribes also used variolation to protect communities during smallpox outbreaks using similar methods. Despite their crude application, these early methods of vaccination demonstrated an intuitive understanding of immunity and laid the groundwork for modern research.

Edward Jenner and the Birth of Modern Vaccination

The pivotal moment in vaccine history came in 1796 with Edward Jenner. Jenner observed that milkmaids exposed to cowpox seemed to become immune to smallpox. He hypothesized that cowpox could protect against smallpox. To test his theory, Jenner inoculated eight-year-old James Phipps with cowpox material from a milkmaid’s pox lesion. When exposed to smallpox, Phipps showed no signs of illness. This transformative experiment marked the genesis of vaccination, a term derived from the Latin vacca (cow). And unlike variolation, Jenner’s method was safer because cowpox posed little risk to humans. His findings, published in 1798, sparked global interest, and smallpox vaccination spread rapidly across Europe and North America.

Jenner’s discovery had profound implications for public health. Smallpox, which had historically killed up to 30% of its victims, leaving survivors scarred or blinded, was now preventable. Vaccination campaigns began in the early 19th century, with governments and medical societies promoting the practice. However, opposition emerged from those who feared the procedure or distrusted medical intervention, foreshadowing modern vaccine hesitancy. Despite these challenges, Jenner’s work proved that controlled exposure to a pathogen could safely stimulate lifelong immunity, laying the foundation for immunology.

The 19th Century: Advancements in Vaccination

The 19th century heralded a transformative period for vaccines, driven by the emergence of germ theory and advancements in medical science. Germ theory established that microorganisms cause infectious diseases, providing a scientific framework for vaccine development. This shift in thinking moved vaccination from an empirical practice to a rigorous discipline that enabled researchers to precisely target specific pathogens.

Louis Pasteur, a French microbiologist, built on Jenner’s legacy by developing vaccines for anthrax and rabies. In 1881, Pasteur created an anthrax vaccine for livestock, using a weakened strain of the anthrax bacterium to stimulate immunity without causing disease. This breakthrough work protected farmers from devastating livestock losses and demonstrated the potential of attenuated pathogens in vaccine design. Pasteur’s rabies vaccine, tested in 1885, was even more groundbreaking because it posed a significant public health threat to a nearly always fatal disease transmitted through animal bites. Pasteur produced a series of injections using an attenuated (weakened) form of the rabies virus, successfully saving the life of Joseph Meister, a young boy bitten by a rabid dog. Pasteur’s work highlighted the weakening of pathogens to create safe vaccines, which became a cornerstone in vaccine development. His achievement not only validated the use of vaccinations but also established him as an immunology pioneer, inspiring the creation of institutions like the Pasteur Institute, dedicated to infectious disease research.

The 19th century also saw public health move to the forefront. Governments began investing in sanitation, quarantine measures, and vaccination campaigns to combat disease outbreaks, marking a shift toward collective responsibility for disease prevention and setting the stage for the widespread immunization programs of the 20th century and beyond.

The 20th Century: Expansion and Controversies

The 20th century was a golden age for vaccines, characterized by rapid scientific advancements and the expansion of public health infrastructure. In the 1920s and 30s, vaccines for diphtheria, tetanus, and pertussis (whooping cough) were developed using various methods. The diphtheria vaccine, introduced in the 1920s, used a detoxified toxin to stimulate immunity. Tetanus and pertussis vaccines were developed in the 1930s and combined with the DTP vaccine to become the cornerstone of childhood immunization programs during the 1940s and 1950s. As vaccination coverage increased, mortality from these diseases plummeted, clearly demonstrating the power of preventive medicine.

In the 1950s, the polio virus, which causes paralysis and death, had outbreaks around the world, with a large epidemic in the US leaving thousands of children disabled. In 1955, Jonas Salk developed the inactivated polio vaccine (IPV) using dead poliovirus to build immunity safely. Its success was swift, resulting in a dramatic drop in polio cases in a short time. Albert Sabin’s oral polio vaccine (OPV) was developed in the early 1960s using a live but weakened virus, making it easier to administer in mass campaigns. The widespread adoption of both of these vaccines has led to polio’s near-elimination, with only Afghanistan and Pakistan still considered endemic.

Despite verifiable successes, the 20th century also saw the rise of various vaccine controversies. Anti-vaccine movements, often based on distrust of medical institutions or specific religious beliefs, gained traction. In the late 19th and early 20th centuries, smallpox vaccine mandates sparked protests in Britain and the United States. These tensions resurfaced in the late 20th century with the 1998 publication of a fraudulent study by Andrew Wakefield, which falsely linked the measles, mumps, and rubella (MMR) vaccine to autism. Though the study was debunked and retracted, it still contributes to vaccine hesitancy today and has ultimately led to the resurgence of measles in regions with declining vaccination rates. These challenges underscore the importance of maintaining public trust, which continues to be a recurring theme throughout medical history.

The Late 20th Century to Today: Innovation and Global Health

The late twentieth century brought significant innovations in vaccine technology and delivery, making them safer, more effective, and more accessible. Combination vaccines, like the MMR and DTP vaccines, simplified immunization schedules and improved compliance. Advances in biotechnology, particularly recombinant DNA technology, enabled the development of treatments like the hepatitis B vaccine, which uses genetically engineered viral proteins to stimulate immunity. This approach eliminated the need to grow live pathogens, enhancing both vaccine safety and scalability.

Global health organizations have played a pivotal role in providing access to vaccines. The World Health Organization’s Expanded Programme on Immunization, launched in 1974, was established to vaccinate children worldwide against tuberculosis, diphtheria, tetanus, pertussis, polio, and measles. These global vaccination campaigns, along with active disease surveillance, contributed to eradicating smallpox in 1980 and was a significant historical milestone. In addition, polio cases dropped by 99%, with the disease endemic in just four countries by 2006, and measles mortality declined significantly due to widespread immunization.

The development of mRNA vaccine technology in the 1990s marked a significant shift in how we understood vaccine development. Unlike traditional vaccines, which use weakened or inactivated pathogens, mRNA vaccines deliver genetic instructions to cells. These instructions prompt cells to produce a protein that triggers the body’s immune response. Though initially experimental, this technology proved transformative during the COVID-19 pandemic. Additional innovations, including conjugate vaccines for diseases like Haemophilus influenzae type b (Hib), have expanded the number of preventable diseases by enhancing the body’s immune response.

In addition, organizations like the Global Alliance for Vaccines and Immunization (GAVI), founded in 2000, worked to address inequities in vaccine access, particularly in low-income countries. By subsidizing vaccine distribution costs and strengthening health systems, GAVI helped to vaccinate millions of children, reducing health disparities and preventing outbreaks, underscoring the importance of global cooperation in achieving public health goals.

The COVID-19 Pandemic: A New Era for Vaccines

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, was another defining moment in vaccine history. When the virus emerged in 2019 and spread rapidly, it prompted an unprecedented global response. Within a year, multiple vaccines were developed, tested, and deployed, a feat that defied traditional timelines, where development often spanned decades. These vaccines instructed cells to produce the SARS-CoV-2 spike protein, prompting an immune response without using the virus. Other vaccines, such as those from AstraZeneca and Johnson & Johnson, used viral vector technology.

The speed of COVID-19 vaccine development resulted from global collaboration, massive funding, and regulatory flexibility. Initiatives like Operation Warp Speed in the US and COVAX globally accelerated research, manufacturing, and distribution. By mid-2021, billions of doses had been administered, significantly reducing hospitalizations and deaths. However, challenges persisted.

Inequitable worldwide distribution of vaccines left low-income countries with limited access, exacerbating global health disparities. In addition, vaccine hesitancy, fueled by misinformation about mRNA technology and distrust in institutions, reduced vaccination rates in some areas. The subsequent emergence of SARS-CoV-2 variants prompted a need for booster shots to sustain immunity, emphasizing the need for adaptive vaccine strategies.

The COVID-19 pandemic demonstrated both the potential and the limitations of vaccinations. The success of mRNA technology has opened new possibilities for combating other diseases, from influenza to cancer, but it’s also exposed systemic issues in global health equity and communication. As the world continues to navigate the aftermath of the COVID-19 pandemic, vaccines remain a critical tool for preventing future crises.

Vaccines: The Key to Public Health and Future Innovations

Vaccines have been a key public health tool for over two centuries, transforming the fight against infectious diseases. From Jenner’s smallpox vaccine to the rapid deployment of COVID-19 vaccines, each milestone has built on the last, expanding our ability to prevent and control pathogens. Vaccines have also eradicated smallpox, nearly eliminated polio, and controlled diseases like measles and diphtheria in many regions. These achievements reflect the power of scientific innovation, global cooperation, and public health commitment.

The future of vaccines is promising, with mRNA and other technologies paving the way for faster, more adaptable vaccines. Research into universal vaccines, which could protect against entire families of viruses, is underway, as well as research to develop vaccines for non-infectious diseases like cancer. However, issues related to vaccine hesitancy, driven by misinformation and distrust, threaten progress, requiring crystal clear communication and community engagement to counter its effects. Most importantly, those in charge of global health policies and vaccine distribution must address global inequities in vaccine access to ensure no population is left vulnerable to preventable diseases.

As a healthcare provider and caregiver, you can support vaccination efforts by staying informed, advocating for equitable policies, and engaging in constructive dialogue about the benefits of vaccinations. While the story is, overall, one of resilience and hope, the next chapter of vaccines depends on our collective involvement.

References

Try Osmosis today! Access your free trial and find out why millions of current and future clinicians and caregivers love learning with us.